Irbesartan/hydrochlorothiazide
Alternative Names: Avalide; Avapro HCT; CoAprovel; KarvezideLatest Information Update: 31 Mar 2015
At a glance
- Originator sanofi-aventis
- Class Antihypertensives; Benzothiadiazines; Biphenyl compounds; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diabetic nephropathies; Hypertension
Most Recent Events
- 31 Mar 2015 Launched for Hypertension in Algeria, Morocco and Philippines (PO) before March 2015
- 03 Oct 2012 Bristol-Myers Squibb intends to terminate its licence for irbesartan/hydrochlorothiazide in all countries, effective 1 January 2013
- 04 Apr 2012 First generic version of irbesartan hydrochlorothiazide launched in the USA